Amanda F Baker

  • 2474 Citations
  • 28 h-Index
1978 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1996 2018

  • 2474 Citations
  • 28 h-Index
  • 53 Article
  • 2 Chapter
Filter
Article
2018
2 Citations (Scopus)

Characterization of carfilzomib-resistant non-small cell lung cancer cell lines

Hanke, N. T., Imler, E., Marron, M. T., Seligmann, B. E., Garland, L. L. & Baker, A. F., May 15 2018, (Accepted/In press) In : Journal of Cancer Research and Clinical Oncology. p. 1-11 11 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cell Line
P-Glycoprotein
Doxorubicin
Autophagy
2017
4 Citations (Scopus)

Detecting in vivo urokinase plasminogen activator activity with a catalyCEST MRI contrast agent

Sinharay, S., Howison, C. M., Baker, A. F. & Pagel, M. M., Jul 1 2017, In : NMR in Biomedicine. 30, 7, e3721.

Research output: Contribution to journalArticle

Plasminogen Activators
Urokinase-Type Plasminogen Activator
Magnetic resonance imaging
Contrast Media
Enzyme activity
2016
8 Citations (Scopus)

Assessing Metabolic Changes in Response to mTOR Inhibition in a Mantle Cell Lymphoma Xenograft Model Using AcidoCEST MRI

Akhenblit, P. J., Hanke, N. T., Gill, A., Persky, D. O., Howison, C. M., Pagel, M. M. & Baker, A. F., 2016, In : Molecular Imaging. 15

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Magnetic resonance
Heterografts
magnetic resonance
Tumors
16 Citations (Scopus)
Endoplasmic Reticulum Stress
Non-Small Cell Lung Carcinoma
Cell Line
Heat-Shock Proteins
Reactive Oxygen Species
13 Citations (Scopus)

MR imaging biomarkers to monitor early response to hypoxia-activated prodrug TH-302 in pancreatic cancer xenografts

Zhang, X., Wojtkowiak, J. W., Martinez, G. V., Cornnell, H. H., Hart, C. P., Baker, A. F. & Gillies, R., May 1 2016, In : PLoS One. 11, 5, e0155289.

Research output: Contribution to journalArticle

pancreatic neoplasms
Prodrugs
Biomarkers
Pancreatic Neoplasms
Heterografts
1 Citation (Scopus)

Promoting adoption of the 3Rs through regulatory qualification

Walker, E. G., Baker, A. F. & Sauer, J. M., 2016, In : ILAR Journal. 57, 2, p. 221-225 5 p.

Research output: Contribution to journalArticle

Animals
drugs
Safety
DDT
Pharmaceutical Preparations
2015
15 Citations (Scopus)

Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models

Chen, L. Q., Howison, C. M., Perry, C. S., Stopeck, A. T., Malm, S. W., Pagel, M. M. & Baker, A. F., May 1 2015, In : Leukemia and Lymphoma. 56, 5, p. 1432-1439 8 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Lymphoma
Cell Line
Heterografts
Acidosis
8 Citations (Scopus)

Evaluation of a Hypoxia Regulated Gene Panel in Ovarian Cancer

Baker, A. F., Malm, S. W., Pandey, R., Laughren, C., Cui, H., Roe, D. & Chambers, S. K., May 22 2015, In : Cancer Microenvironment. 8, 1, p. 45-56 12 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Nuclease Protection Assays
Genes
Heterografts
Reverse Transcription
9 Citations (Scopus)

Radiosensitization of Hs-766T pancreatic tumor xenografts in mice dosed with dodecafluoropentane nano-emulsion-preliminary findings

Johnson, J. L. H., Leos, R. A., Baker, A. F. & Unger, E. C., Feb 1 2015, In : Journal of Biomedical Nanotechnology. 11, 2, p. 274-281 8 p.

Research output: Contribution to journalArticle

Emulsions
Heterografts
Tumors
Radiation
Neoplasms
19 Citations (Scopus)

The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines

Malm, S. W., Hanke, N. T., Gill, A., Carbajal, L. & Baker, A. F., Apr 1 2015, In : Journal of Experimental and Clinical Cancer Research. 34, 1, 31.

Research output: Contribution to journalArticle

Deoxyglucose
Hypoxia-Inducible Factor 1
Cell Line
Neoplasms
Glucose
2014
20 Citations (Scopus)

Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models

Baker, A. F., Hanke, N. T., Sands, B. J., Carbajal, L., Anderl, J. L. & Garland, L. L., 2014, In : Journal of Experimental and Clinical Cancer Research. 33, 1, 111.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Neoplasms
Lung Neoplasms
Cell Line
Heterografts
1 Citation (Scopus)

Clinical and economic burden of Richter syndrome in inpatient cases of chronic lymphocytic leukemia within the United States, 2001-2010

Skrepnek, G. H., Tate, W. R. & Baker, A. F., 2014, In : Leukemia and Lymphoma. 55, 4, p. 834-840 7 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Inpatients
Economics
Length of Stay
Cost of Illness
32 Citations (Scopus)

Detection of in vivo enzyme activity with CatalyCEST MRI

Yoo, B., Sheth, V. R., Howison, C. M., Douglas, M. J. K., Pineda, C. T., Maine, E. A., Baker, A. F. & Pagel, M. M., Mar 2014, In : Magnetic Resonance in Medicine. 71, 3, p. 1221-1230 10 p.

Research output: Contribution to journalArticle

Plasminogen Activators
Urokinase-Type Plasminogen Activator
Enzymes
Neoplasms
Pharmacokinetics
9 Citations (Scopus)

Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug th-302 in pancreatic cancer

Bailey, K. M., Cornnell, H. H., Ibrahim-Hashim, A., Wojtkowiak, J. W., Hart, C. P., Zhang, X., Leos, R., Martinez, G. V., Baker, A. F. & Gillies, R. J., Dec 22 2014, In : PLoS One. 9, 12

Research output: Contribution to journalArticle

pancreatic neoplasms
Prodrugs
Pancreatic Neoplasms
Tumors
hypoxia
34 Citations (Scopus)

Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)

Dragovich, T., Laheru, D., Dayyani, F., Bolejack, V., Smith, L., Seng, J., Burris, H., Rosen, P., Hidalgo, M., Ritch, P., Baker, A. F., Raghunand, N., Crowley, J. & Von Hoff, D. D., 2014, In : Cancer Chemotherapy and Pharmacology. 74, 2, p. 379-387 9 p.

Research output: Contribution to journalArticle

gemcitabine
Adenocarcinoma
Vascular Endothelial Growth Factor Receptor
Survival Rate
Pancreatic Neoplasms
13 Citations (Scopus)

Reproducibility of magnetic resonance perfusion imaging

Zhang, X., Pagel, M. M., Baker, A. F. & Gillies, R. J., Feb 25 2014, In : PLoS One. 9, 2, e89797.

Research output: Contribution to journalArticle

Gadolinium DTPA
Magnetic Resonance Angiography
Magnetic resonance
magnetic resonance imaging
reproducibility
2013
27 Citations (Scopus)

A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers

Baker, A. F., Adab, K. N., Raghunand, N., Chow, H-H., Stratton, S. P., Squire, S. W., Boice, M., Pestano, L. A., Kirkpatrick, D. L. & Dragovich, T., Jun 2013, In : Investigational New Drugs. 31, 3, p. 631-641 11 p.

Research output: Contribution to journalArticle

Thioredoxins
Gastrointestinal Neoplasms
Fibroblast Growth Factor 2
Pharmacokinetics
Exhalation

Investigation of bendamustine HCL in a Phase 2 study in women with resistant ovarian cancer

Baker, A. F., Roe, D., Laughren, C., Cohen, J. L., Wright, H. M., Clouser, M. C., Cui, H., Alberts, D. S. & Chambers, S. K., Feb 2013, In : Investigational New Drugs. 31, 1, p. 160-166 7 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Keratin-18
Peritoneal Cavity
Caspases
Platinum
10 Citations (Scopus)

Opportunities and challenges of safety biomarker qualification: perspectives from the predictive safety testing consortium

Dennis, E. H., Walker, E. G., Baker, A. F. & Miller, R. T., Mar 2013, In : Drug Development Research. 74, 2, p. 112-126 15 p.

Research output: Contribution to journalArticle

Biomarkers
Safety
Pharmaceutical Preparations
United States Food and Drug Administration
Public-Private Sector Partnerships
2012
35 Citations (Scopus)

IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines

Block, K. M., Hanke, N. T., Maine, E. A. & Baker, A. F., Jul 2012, In : Pancreas. 41, 5, p. 773-781 9 p.

Research output: Contribution to journalArticle

Proto-Oncogene Proteins c-pim-1
STAT3 Transcription Factor
Pancreatic Neoplasms
Interleukin-6
Cell Line
17 Citations (Scopus)

Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model

Cárdenas-Rodríguez, J., Li, Y., Galons, J-P., Cornnell, H., Gillies, R. J., Pagel, M. M. & Baker, A. F., Sep 2012, In : Magnetic Resonance Imaging. 30, 7, p. 1002-1009 8 p.

Research output: Contribution to journalArticle

Prodrugs
Biomarkers
Heterografts
Magnetic resonance
Imaging techniques
8 Citations (Scopus)

Monitoring the development of xenograft triple-negative breast cancer models using diffusion-weighted magnetic resonance imaging

Stephen, R. M., Pagel, M. M., Brown, K., Baker, A. F., Meuillet, E. & Gillies, R. J., Nov 1 2012, In : Experimental Biology and Medicine. 237, 11, p. 1273-1280 8 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Diffusion Magnetic Resonance Imaging
Magnetic resonance
Heterografts
Tumors
65 Citations (Scopus)

TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: Optimization of dosing regimens and schedules

Liu, Q., Sun, J. D., Wang, J., Ahluwalia, D., Baker, A. F., Cranmer, L. D., Ferraro, D., Wang, Y., Duan, J. X., Ammons, W. S., Curd, J. G., Matteucci, M. D. & Hart, C. P., Jun 2012, In : Cancer Chemotherapy and Pharmacology. 69, 6, p. 1487-1498 12 p.

Research output: Contribution to journalArticle

Prodrugs
Appointments and Schedules
irinotecan
temozolomide
docetaxel
2011
32 Citations (Scopus)

Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase

Kim, Y. H., Coon, A., Baker, A. F. & Powis, G., Aug 2011, In : Cancer Chemotherapy and Pharmacology. 68, 2, p. 405-413 9 p.

Research output: Contribution to journalArticle

Thioredoxins
Spermidine
Spermine
Transferases
Antineoplastic Agents
64 Citations (Scopus)

A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination

Ramanathan, R. K., Abbruzzese, J., Dragovich, T., Kirkpatrick, L., Guillen, J. M., Baker, A. F., Pestano, L. A., Green, S. & Von Hoff, D. D., Mar 2011, In : Cancer Chemotherapy and Pharmacology. 67, 3, p. 503-509 7 p.

Research output: Contribution to journalArticle

gemcitabine
Thioredoxins
Odors
Metabolites
Pancreatic Neoplasms
22 Citations (Scopus)

Management strategies in pancreatic cancer

Campen, C. J., Dragovich, T. & Baker, A. F., Apr 1 2011, In : American Journal of Health-System Pharmacy. 68, 7, p. 573-584 12 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
gemcitabine
Drug Therapy
Combined Modality Therapy
Nanotechnology
2010
46 Citations (Scopus)

Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer

Chambers, S. K., Clouser, M. C., Baker, A. F., Roe, D., Cui, H., Brewer, M. A., Hatch, K. D., Gordon, M. S., Janicek, M. F., Isaacs, J. D., Gordon, A. N., Nagle, R. B., Wright, H. M., Cohen, J. L. & Alberts, D. S., Nov 1 2010, In : Clinical Cancer Research. 16, 21, p. 5320-5328 9 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Vascular Endothelial Growth Factor A
Disease-Free Survival
Neoplasms
Nasal Septal Perforation
2008
37 Citations (Scopus)

Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1α-induced gene in pancreatic cancer

Baker, A. F., Koh, M. Y., Williams, R. R., James, B., Wang, H., Tate, W. R., Gallegos, A., Von Hoff, D. D., Han, H. & Powis, G., Mar 2008, In : Pancreas. 36, 2, p. 178-186 9 p.

Research output: Contribution to journalArticle

Hypoxia-Inducible Factor 1
Thioredoxins
Pancreatic Neoplasms
Genes
Proteins
2007
58 Citations (Scopus)

A phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors

Ramanathan, R. K., Kirkpatrick, D. L., Belani, C. P., Friedland, D., Green, S. B., Chow, H-H., Cordova, C. A., Stratton, S. P., Shadow, E. R., Baker, A. F. & Dragovich, T., Apr 1 2007, In : Clinical Cancer Research. 13, 7, p. 2109-2114 6 p.

Research output: Contribution to journalArticle

Thioredoxins
Pharmacokinetics
Neoplasms
Pneumonia
Appointments and Schedules
15 Citations (Scopus)

The antitumor agent imexon activates antioxidant gene expression: Evidence for an oxidative stress response

Baker, A. F., Landowski, T. H., Dorr, R. T., Tate, W. R., Gard, J. M. C., Tavenner, B. E., Dragovich, T., Coon, A. & Powis, G., Jun 1 2007, In : Clinical Cancer Research. 13, 11, p. 3388-3394 7 p.

Research output: Contribution to journalArticle

Antineoplastic Agents
Oxidative Stress
Antioxidants
Gene Expression
GATA1 Transcription Factor
2006
35 Citations (Scopus)

Lenalidomide: Targeted anemia therapy for myelodysplastic syndromes

List, A. F., Baker, A. F., Green, S. & Bellamy, W., 2006, In : Cancer Control. 13, SUPPL., p. 4-11 8 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Anemia
Chromosome Deletion
Erythropoiesis
Cytogenetics
283 Citations (Scopus)

Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127

Dragovich, T., McCoy, S., Fenoglio-Preiser, C. M., Wang, J., Benedetti, J. K., Baker, A. F., Hackett, C. B., Urba, S. G., Zaner, K. S., Blanke, C. D. & Abbruzzese, J. L., Oct 20 2006, In : Journal of Clinical Oncology. 24, 30, p. 4922-4927 6 p.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Adenocarcinoma
Epidermal Growth Factor Receptor
Erlotinib Hydrochloride
3 Citations (Scopus)

Suppressor of cytokine signaling-3 is overexpressed in erythroid precursors of myelodysplastic syndrome [2]

Baker, A. F., Bellamy, W., Tate, W. R., Bair, W. B., Heaton, R. & List, A. F., Sep 2006, In : Leukemia. 20, 9, p. 1620-1621 2 p.

Research output: Contribution to journalArticle

Suppressor of Cytokine Signaling Proteins
Erythroid Precursor Cells
DNA Primers
Myelodysplastic Syndromes
DNA Probes
74 Citations (Scopus)

The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma

Baker, A. F., Dragovich, T., Tate, W. R., Ramanathan, R. K., Roe, D., Hsu, C-H., Kirkpatrick, D. L. & Powis, G., Feb 2006, In : The Journal of Laboratory and Clinical Medicine. 147, 2, p. 83-90 8 p.

Research output: Contribution to journalArticle

Thioredoxins
Vascular Endothelial Growth Factor A
Plasmas
Neoplasms
Tumors
28 Citations (Scopus)

The skin and hair as surrogate tissues for measuring the target effect of inhibitors of phosphoinositide-3-kinase signaling

Williams, R., Baker, A. F., Ihle, N. T., Winkler, A. R., Kirkpatrick, L. & Powis, G., Oct 2006, In : Cancer Chemotherapy and Pharmacology. 58, 4, p. 444-450 7 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinase
1-Phosphatidylinositol 4-Kinase
Phosphatidylinositols
Hair
Tumors
2005
110 Citations (Scopus)

Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1α using PX-478

Jordan, B. F., Runquist, M., Raghunand, N., Baker, A. F., Williams, R., Kirkpatrick, L., Powis, G. & Gillies, R. J., May 2005, In : Neoplasia. 7, 5, p. 475-485 11 p.

Research output: Contribution to journalArticle

Diffusion Magnetic Resonance Imaging
Tumor Microenvironment
Capillary Permeability
Neoplasms
Clinical Trials
131 Citations (Scopus)

Stability of phosphoprotein as a biological marker of tumor signaling

Baker, A. F., Dragovich, T., Ihle, N. T., Williams, R., Fenoglio-Preiser, C. & Powis, G., Jun 15 2005, In : Clinical Cancer Research. 11, 12, p. 4338-4340 3 p.

Research output: Contribution to journalArticle

Phosphoproteins
Tumor Biomarkers
Heterografts
Neoplasms
Staining and Labeling
141 Citations (Scopus)

The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenografts

Ihle, N. T., Paine-Murrieta, G., Berggren, M. I., Baker, A. F., Tate, W. R., Wipf, P., Abraham, R. T., Kirkpatrick, D. L. & Powis, G., Sep 2005, In : Molecular Cancer Therapeutics. 4, 9, p. 1349-1357 9 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinase
Epidermal Growth Factor Receptor
Heterografts
Non-Small Cell Lung Carcinoma
pioglitazone
47 Citations (Scopus)

The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging

Jordan, B. F., Runquist, M., Raghunand, N., Gillies, R. J., Tate, W. R., Powis, G. & Baker, A. F., Jan 15 2005, In : Clinical Cancer Research. 11, 2 I, p. 529-536 8 p.

Research output: Contribution to journalArticle

Thioredoxins
Capillary Permeability
Heterografts
Magnetic Resonance Imaging
Vascular Endothelial Growth Factor A
2004
54 Citations (Scopus)

In vivo molecular pharmacology and antitumor activity of the targeted Akt inhibitor PX-316

Meuillet, E., Ihle, N., Baker, A. F., Gard, J. M., Stamper, C., Williams, R., Coon, A., Mahadevan, D., George, B. L., Kirkpatrick, L. & Powis, G., 2004, In : Oncology Research. 14, 10, p. 513-527 15 p.

Research output: Contribution to journalArticle

Pharmacology
Phosphatidylinositols
Heterografts
Phosphatidylinositol 3-Kinase
Glycogen Synthase Kinase 3
2001
84 Citations (Scopus)

Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth

Tome, M. E., Baker, A. F., Powis, G., Payne, C. M. & Briehl, M. M., Mar 15 2001, In : Cancer Research. 61, 6, p. 2766-2773 8 p.

Research output: Contribution to journalArticle

Thymocytes
Catalase
Glucocorticoids
Apoptosis
Growth
47 Citations (Scopus)

Drug interactions with the taxanes: Clinical implications

Baker, A. F. & Dorr, R. T., 2001, In : Cancer Treatment Reviews. 27, 4, p. 221-233 13 p.

Research output: Contribution to journalArticle

Taxoids
Paclitaxel
Drug Interactions
docetaxel
Anticonvulsants
95 Citations (Scopus)
Peroxiredoxins
Thioredoxins
Etoposide
Doxorubicin
Hydrogen Peroxide
2000
44 Citations (Scopus)

Redox control of caspase-3 activity by thioredoxin and other reduced proteins

Baker, A. F., Santos, B. D. & Powis, G., Feb 5 2000, In : Biochemical and Biophysical Research Communications. 268, 1, p. 78-81 4 p.

Research output: Contribution to journalArticle

Thioredoxins
Caspase 3
Oxidation-Reduction
Proteins
Caspases
1998
4 Citations (Scopus)

Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediols

Dorr, R. T., Bellamy, W., Liddil, J. D., Baker, A. F. & Bair, K. W., Oct 1998, In : Anti-Cancer Drug Design. 13, 7, p. 825-835 11 p.

Research output: Contribution to journalArticle

DNA Breaks
Cytotoxicity
DNA
Assays
Type II DNA Topoisomerase
88 Citations (Scopus)

Thioredoxin redox control of cell growth and death and the effects of inhibitors

Powis, G., Kirkpatrick, D. L., Angulo, M. & Baker, A. F., Apr 24 1998, In : Chemico-Biological Interactions. 111-112, p. 23-34 12 p.

Research output: Contribution to journalArticle

Thioredoxins
Cell growth
Cell death
Oxidation-Reduction
Cell Death
1997
45 Citations (Scopus)

Modulation of antioxidant defenses during apoptosis

Briehl, M. M., Baker, A. F., Siemankowski, L. M. & Morreale, J., 1997, In : Oncology Research. 9, 6-7, p. 281-285 5 p.

Research output: Contribution to journalArticle

Antioxidants
Apoptosis
Dexamethasone
Lymphocytes
Glutathione Transferase

Redox signaling and the control of cell growth and death.

Powis, G., Gasdaska, J. R. & Baker, A., 1997, In : Advances in Pharmacology. 38, p. 329-359 31 p.

Research output: Contribution to journalArticle

Cell Division
Oxidation-Reduction
Signal Transduction
Cell Death
Apoptosis
66 Citations (Scopus)

Selenium and the thioredoxin redox system: Effects on cell growth and death

Powis, G., Gasdaska, J. R., Gasdaska, P. Y., Berggren, M., Lynn Kirkpatrick, D., Engman, L., Cotgreave, I. A., Angulo, M. & Baker, A. F., 1997, In : Oncology Research. 9, 6-7, p. 303-312 10 p.

Research output: Contribution to journalArticle

Thioredoxins
Selenium
Thioredoxin-Disulfide Reductase
Oxidation-Reduction
Cell Death
215 Citations (Scopus)

Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo

Baker, A. F., Payne, C. M., Briehl, M. M. & Powis, G., Nov 15 1997, In : Cancer Research. 57, 22, p. 5162-5167 6 p.

Research output: Contribution to journalArticle

Thioredoxins
Apoptosis
Genes
Neoplasms
Dexamethasone